VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F950. A total of 9 filers reported holding VERTEX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,466,974 | +42.3% | 30,100 | +44.0% | 0.04% | +45.8% |
| Q2 2023 | $7,354,919 | +63.2% | 20,900 | +46.2% | 0.02% | +50.0% |
| Q1 2023 | $4,505,501 | -65.1% | 14,300 | -68.0% | 0.02% | -46.7% |
| Q4 2022 | $12,908,466 | -69.7% | 44,700 | -69.7% | 0.03% | -64.3% |
| Q3 2022 | $42,649,000 | -32.5% | 147,300 | -34.3% | 0.08% | -15.2% |
| Q2 2022 | $63,177,000 | +120.7% | 224,200 | +104.4% | 0.10% | +253.6% |
| Q1 2022 | $28,628,000 | -20.5% | 109,700 | -33.1% | 0.03% | -3.4% |
| Q4 2021 | $35,992,000 | +63.3% | 163,900 | +34.9% | 0.03% | +20.8% |
| Q3 2021 | $22,039,000 | -34.3% | 121,500 | -26.9% | 0.02% | -40.0% |
| Q2 2021 | $33,531,000 | -15.8% | 166,300 | -10.3% | 0.04% | -32.2% |
| Q1 2021 | $39,819,000 | -12.8% | 185,300 | -4.1% | 0.06% | -25.3% |
| Q4 2020 | $45,685,000 | +276.4% | 193,300 | +333.4% | 0.08% | +107.9% |
| Q3 2020 | $12,137,000 | +309.9% | 44,600 | +337.3% | 0.04% | +171.4% |
| Q2 2020 | $2,961,000 | -58.4% | 10,200 | -65.9% | 0.01% | -75.9% |
| Q1 2020 | $7,115,000 | -41.3% | 29,900 | -46.0% | 0.06% | -30.1% |
| Q4 2019 | $12,130,000 | +165.2% | 55,400 | +105.2% | 0.08% | +124.3% |
| Q3 2019 | $4,574,000 | -27.3% | 27,000 | -21.3% | 0.04% | -35.1% |
| Q2 2019 | $6,290,000 | -9.3% | 34,300 | -9.0% | 0.06% | -26.0% |
| Q1 2019 | $6,935,000 | -38.9% | 37,700 | -45.0% | 0.08% | -21.4% |
| Q4 2018 | $11,351,000 | +65.0% | 68,500 | +91.9% | 0.10% | +81.5% |
| Q3 2018 | $6,881,000 | +5.2% | 35,700 | -7.3% | 0.05% | -3.6% |
| Q2 2018 | $6,543,000 | -7.1% | 38,500 | -10.9% | 0.06% | -21.1% |
| Q1 2018 | $7,041,000 | -34.4% | 43,200 | -39.7% | 0.07% | -5.3% |
| Q4 2017 | $10,730,000 | -29.4% | 71,600 | -28.3% | 0.08% | -45.7% |
| Q3 2017 | $15,189,000 | +71.6% | 99,900 | +45.4% | 0.14% | +50.0% |
| Q2 2017 | $8,853,000 | +2.7% | 68,700 | -12.8% | 0.09% | -8.0% |
| Q1 2017 | $8,617,000 | +137.3% | 78,800 | +59.8% | 0.10% | +185.7% |
| Q4 2016 | $3,632,000 | +140.7% | 49,300 | +185.0% | 0.04% | +118.8% |
| Q3 2016 | $1,509,000 | -29.6% | 17,300 | -30.5% | 0.02% | -36.0% |
| Q2 2016 | $2,142,000 | +98.1% | 24,900 | +83.1% | 0.02% | +66.7% |
| Q1 2016 | $1,081,000 | -17.4% | 13,600 | +30.8% | 0.02% | 0.0% |
| Q4 2015 | $1,309,000 | -27.8% | 10,400 | -40.2% | 0.02% | -40.0% |
| Q3 2015 | $1,812,000 | -34.8% | 17,400 | -22.7% | 0.02% | -35.9% |
| Q2 2015 | $2,778,000 | +17.8% | 22,500 | +12.5% | 0.04% | +5.4% |
| Q1 2015 | $2,359,000 | -95.2% | 20,000 | -95.1% | 0.04% | -95.0% |
| Q4 2014 | $48,934,000 | +0.6% | 411,900 | -4.9% | 0.74% | -1.3% |
| Q3 2014 | $48,619,000 | +191.9% | 432,900 | +146.1% | 0.75% | +191.4% |
| Q2 2014 | $16,654,000 | +64.6% | 175,900 | +22.9% | 0.26% | +51.2% |
| Q1 2014 | $10,120,000 | -29.2% | 143,100 | -25.6% | 0.17% | -21.3% |
| Q4 2013 | $14,288,000 | +83.3% | 192,300 | +87.1% | 0.22% | +45.0% |
| Q3 2013 | $7,794,000 | -41.6% | 102,800 | -38.5% | 0.15% | -54.7% |
| Q2 2013 | $13,346,000 | – | 167,100 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 224,200 | $63,177,000 | 0.10% |
| Twin Tree Management, LP | 54,800 | $15,442,000 | 0.02% |
| JANE STREET GROUP, LLC | 161,500 | $45,509,000 | 0.02% |
| SIMPLEX TRADING, LLC | 54,100 | $15,244,000 | 0.02% |
| SG Americas Securities, LLC | 20,000 | $170,000 | 0.00% |
| JPMORGAN CHASE & CO | 6,400 | $1,803,000 | 0.00% |
| Allianz Asset Management GmbH | 500 | $141,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |